926.15
0.61%
KRChoksey
For Q3FY24, TATVA revenue was INR 842 Mn which declined by 30.2% YoY and 12.9% QoQ. This significant decline was due to continued subdued demand for the specialty chemical industry and financial year-end for global end customers.
Tatva Chintan Pharma Chem Ltd. has gained 24.73% in the last 1 Month
More from Tatva Chintan Pharma Chem Ltd.
Recommended